Condition: Tuberculosis (TB) · End-Stage Kidney Disease · Sponsor: Mahidol University
This is an observational study among approximately 160 end-stage renal disease patients on renal replacement therapy and post-living donor or deceased donor kidney transplant recipients. Investigators aim to assess the proportion of positive IGRA associated with symptom development, sputum Xpert MTB/RIF assay, and chest radiograph to define latent TB infection and subclinical TB among ESKD and renal transplant patients.
This description comes directly from the study's public registry record.
Tanaya Siripoon, M.D. · 6626435599 · Tanaya.sir@mahidol.edu
Punnee Pitisuttithum, Prof. E. · 6626435599 · punnee.pit@mahidol.ac.th
Always discuss trial participation with your own doctor first.
| Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University | Bangkok, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06700876